High Dose Ocrelizumab as Off-Label Treatment in Patients with Insufficient Response to Standard Dose

AuthID
 P-017-PM5
13
Author(s)
Soares, MD
·
Gomes, I
·
Sequeira, J
·
Sousa, A
·
Grine, T
·
Silva, AI
·
Mateus, C
·
Encarnaçao, S
·
Gama, A
·
Arriegas, C
·
Capela, C
Tipo de Documento
Abstract
Year published
2024
Publicado
in MULTIPLE SCLEROSIS JOURNAL, ISSN: 1352-4585
Volume: 30, Número: 3, Páginas: 1074-1074 (1)
Conference
40Th Congress of the European-Committee-For-Treatment-And-Research-In-Multiple-Sclerosis (Ectrims), Date: SEP 18-20, 2024, Location: Copenhagen, DENMARK
Indexing
Wos®
Publication Identifiers
Wos: WOS:001324906903269
Source Identifiers
ISSN: 1352-4585
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Info
At this moment we don't have any links to full text documens.

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2025 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service